Apolipoprotein A-I agonists and their use to treat dyslipidemic disorders
The present invention provides peptides and peptide analogues that mimic the
structural and pharmacological properties of human ApoA-I. The peptides and peptide
analogues are useful to treat a variety of disorders associated with dyslipidemia.